TrialEuropean heart journal2009

Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists.

Gregory Y H Lip et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.